Adagene Interest Expense 2011-2026 | ADAG

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Adagene

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	1.11 M	693 K	364 K	202 K	138 K	91.1 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.11 M	91.1 K	433 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	23 K	$ 21.77	1.68 %	$ 1.02 B	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	1.82 M	$ 22.44	2.16 %	$ 3.72 B	USA
Esperion Therapeutics ESPR	3.49 M	$ 2.02	5.76 %	$ 420 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Galectin Therapeutics GALT	1.03 M	$ 2.42	3.65 %	$ 155 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	8 K	-	-	$ 28.6 M	USA
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Heron Therapeutics HRTX	1.34 M	$ 1.26	6.3 %	$ 210 M	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
ImmuCell Corporation ICCC	349 K	$ 8.28	-0.84 %	$ 74.7 M	USA
Brainstorm Cell Therapeutics BCLI	-93 K	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	-27 K	-	-	$ 8.42 M	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
InflaRx N.V. IFRX	2.69 K	$ 1.53	3.38 %	$ 152 M	Germany
BioNTech SE BNTX	14.2 M	$ 103.31	-2.04 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	6.55 M	$ 4.14	1.47 %	$ 443 M	USA
Arcutis Biotherapeutics ARQT	443 K	$ 23.57	1.33 %	$ 3 B	USA
Innate Pharma S.A. IPHA	440 K	$ 1.39	0.72 %	$ 235 M	France
Inventiva S.A. IVA	12.2 M	$ 5.18	0.49 %	$ 138 M	France
Jaguar Health JAGX	67 K	$ 0.36	-8.39 %	$ 840 K	USA
Autolus Therapeutics plc AUTL	36.7 M	$ 1.46	1.04 %	$ 389 M	Britain
KalVista Pharmaceuticals KALV	8.56 M	$ 20.08	2.29 %	$ 1.08 B	Britain
Can-Fite BioPharma Ltd. CANF	227 K	$ 2.99	2.05 %	$ 4.92 M	Israel
BioDelivery Sciences International BDSI	-6 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	-42.6 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA